Authors: SCHMOLL HJ QUIETZSCH D BORNER P KETTNER E MENNIGEN R ZINGREBE M PREISS J

Citation: Hj. Schmoll et al., SAFETY OF ADJUVANT MAB 17-1A IN COLORECTAL-CANCER (CRC), European journal of cancer, 33, 1997, pp. 750-750

Authors: LINK KH STAIB L BERNHART H KREUSER ED SUHR P ROTTINGER E BEGER HG KRAUTZBERGER W BEWERSDORF H KAHLE M SCHWANGHART F KARN B SCHMELZ M RUNKEL N BAER U SEMLER P LUDTKEHANDJERY A RUPPEL FJ AUGENSTEIN H ENGEL R THOLL U MEISSNER D KLIEBISCH S PAUL U PLATZ M SCHMIDT W KUHLGATZ J HENZLER M SCHRAMM H TEICHER R STELZER E BAUMANN W KURRLE E BUCHELT L LIERSCH T MAO R HECKER U WACKE W GOTH B BRULLKE N VOGT J MEUSEL P STEINHAUER EU KNUFERMANN H LANDES T VEHLINGKAISER U SCHENKER U KOGEL H JOST KA MENTZEL M KUJATH P ZERBIAN KU LORENZ S AHLEMANN LM MOKROS W KETTNER E RIDWELSKI K ROSCHER R LANGE J RATH W EBERT KH FISCHER M SCHERBER A BECK J FUHLROTT M LENZ P GABRIEL P BARTEL F WEISER HF SCHUTZE F MULLER C ALBRECHT J BOTHIG R FRANK R LEIBL B PATSAS JR WEBER W RENDENBACH B SCHMIDT R LUTZ M SCHNEIDERKAPPUS W SCHNEIDER M SIMANK P DISEBASTIANO P

Citation: Kh. Link et al., ACCEPTANCE AND TOXICITY OF POSTOPERATIVE ADJUVANT THERAPY IN COLON AND RECTAL CANCERS - INTERIM REPORT ON THE TRIALS FOGT1 AND FOGT2 OF THEGERMAN SCHUNGSGRUPPE-ONKOLOGIE-GASTROINTESTINALER-TUMOREN (FOGT), Onkologie, 20(3), 1997, pp. 235-238

Authors: KOHLER U OLBRICHT SS FUECHSEL G KETTNER E RICHTER B RIDWELSKI K

Citation: U. Kohler et al., WEEKLY PACLITAXEL WITH EPIRUBICIN AS 2ND-LINE THERAPY OF METASTATIC BREAST-CANCER - RESULTS OF A CLINICAL-PHASE-II STUDY, Seminars in oncology, 24(5), 1997, pp. 40-43

Authors: KRONING H TAGER M THIEL U ITTENSON A REINHOLD D BUHLING F KETTNER E ANSORGE S

Citation: H. Kroning et al., OVERPRODUCTION OF IL-7, IL-10 AND TGF-BETA-1 IN MULTIPLE-MYELOMA, Acta haematologica, 98(2), 1997, pp. 116-118